Figure 2.
Blue spots show 339 patients with nonhyperprogressing disease (non-HPD). Red spots show 38 patients with hyperprogressive disease (HPD) during PD-1 inhibitor therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.